U.S. Biotech Leadership at Risk The National Security Commission on Emerging Biotechnology delivered a major report to Congress with a stark warning that the U.S. biotech sector is at risk of falling behind China unless the government and researchers swiftly step up investment and support. The report outlined grave risks to American security and prosperity: Based on two years of research and consultation with private and public experts, this report comes to a sobering, even frightening, conclusion: China is quickly ascending to biotechnology dominance, having made biotechnology a strategic priority for 20 years. To remain competitive, the United States must take swift action in the next three years. Otherwise, we risk falling
